PREVALENCE, RISK FACTORS, MANAGEMENT, OUTCOMES, AND PREDICTORS OF MORTALITY IN RETROPERITONEAL HEMATOMA AFTER PERCUTANEOUS CORONARY INTERVENTION

Y SAOOD; M ASIM; A SALMAN; MI KHAN; R ZAFAR; SIA KAZMI

doi:10.54112/bcsrj.v2023i1.435

Authors

Y SAOOD Department of Cardiology, Ayub Teaching Hospital Abbottabad, Pakistan
M ASIM DHQ Hospital Batkhela, Pakistan
A SALMAN Department of Cardiology, Saidu Medical College / Saidu Group of Teaching Hospital Swat, Pakistan
MI KHAN Department of Cardiology, Peshawar Institute of Cardiology, Pakistan
R ZAFAR Department of Medicine, Teaching Hospital Kech, Turbat, Pakistan
SIA KAZMI Department of Cardiology, Women Medical College Abbottabad, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2023i1.435

Keywords:

Femoral Artery, Punctures, Hematoma, Retroperitoneal, Coronary Angiography, Percutaneous Coronary Intervention, Risk Factors, Prevalence, Mortality

Abstract

The development of complications related to femoral artery puncture continues to be frequent following contemporary percutaneous coronary intervention (PCI). The basic aim of the study is to find retroperitoneal hematoma after percutaneous coronary intervention prevalence, risk factors, management, outcomes, and predictors of mortality. This retrospective cohort study was conducted at the Peshawar Institute of Cardiology, Peshawar, from January 2022 to April 2023. The study population consisted of patients who underwent PCI procedures. Sixty-eight patients who developed RPH after PCI were included in the analysis. Demographic information such as age, gender, and relevant baseline characteristics of the patients was recorded. Clinical variables encompassed comorbidities (e.g., hypertension, diabetes mellitus), the indication for PCI (e.g., stable angina, acute coronary syndrome), and procedural details, including the access site and anticoagulant medications. Data was collected from 68 patients. The mean age of patients who developed RPH was 63.7 years, ranging from 45 to 78 years. Gender distribution showed 60% male and 40% female patients. Common comorbidities among this cohort included hypertension (80% of cases) and diabetes mellitus (45% of cases). The study identified several risk factors associated with the development of RPH post-PCI, including female gender (p < 0.05), anticoagulant use (p < 0.01), and hypertension (p < 0.05), which demonstrated a statistically significant association. Based on the results, the study provides valuable insights into the prevalence, risk factors, management strategies, clinical outcomes, and predictors of mortality associated with RPH following PCI.

Downloads

Download data is not yet available.

References

Ahmed, M., Keshava, S. N., Moses, V., and Valson, A. T. (2018). Endovascular management of a large retroperitoneal haemorrhage resulting from dual testicular and intra-renal arterial injury after renal biopsy. Indian Journal of Radiology and Imaging 28, 362-365.

Dencker, D., Pedersen, F., Engstrøm, T., Køber, L., Højberg, S., Nielsen, M. B., Schroeder, T. V., and Lönn, L. (2016). Major femoral vascular access complications after coronary diagnostic and interventional procedures: a Danish register study. International Journal of Cardiology 202, 604-608.

Duvernoy, C. S., Smith, D. E., Manohar, P., Schaefer, A., Kline-Rogers, E., Share, D., McNamara, R., Gurm, H. S., and Moscucci, M. (2010). Gender differences in adverse outcomes after contemporary percutaneous coronary intervention: an analysis from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) percutaneous coronary intervention registry. American heart journal 159, 677-683. e1.

Farouque, H. O., Tremmel, J. A., Raissi Shabari, F., Aggarwal, M., Fearon, W. F., Ng, M. K., Rezaee, M., Yeung, A. C., and Lee, D. P. (2005). Risk factors for the development of retroperitoneal hematoma after percutaneous coronary intervention in the era of glycoprotein IIb/IIIa inhibitors and vascular closure devices. Journal of the American College of Cardiology 45, 363-368.

French, J. T., Goins, B., Saenz, M., Li, S., Garcia-Rojas, X., Phillips, W. T., Otto, R. A., and Bao, A. (2010). Interventional therapy of head and neck cancer with lipid nanoparticle–carried rhenium 186 radionuclide. Journal of vascular and interventional radiology 21, 1271-1279.

Giacoppo, D., Madhavan, M. V., Baber, U., Warren, J., Bansilal, S., Witzenbichler, B., Dangas, G. D., Kirtane, A. J., Xu, K., and Kornowski, R. (2015). Impact of contrast-induced acute kidney injury after percutaneous coronary intervention on short-and long-term outcomes: pooled analysis from the HORIZONS-AMI and ACUITY trials. Circulation: Cardiovascular Interventions 8, e002475.

Kinnaird, T., Kwok, C. S., Kontopantelis, E., Ossei-Gerning, N., Ludman, P., deBelder, M., Anderson, R., and Mamas, M. A. (2016). Incidence, determinants, and outcomes of coronary perforation during percutaneous coronary intervention in the United Kingdom between 2006 and 2013: an analysis of 527 121 cases from the British Cardiovascular Intervention Society Database. Circulation: Cardiovascular Interventions 9, e003449.

Kwok, C. S., Kontopantelis, E., Kinnaird, T., Potts, J., Rashid, M., Shoaib, A., Nolan, J., Bagur, R., De Belder, M. A., and Ludman, P. (2018). Retroperitoneal hemorrhage after percutaneous coronary intervention: incidence, determinants, and outcomes as recorded by the British Cardiovascular Intervention Society. Circulation: Cardiovascular Interventions 11, e005866.

Means, G., End, C., and Kaul, P. (2017). Management of percutaneous coronary intervention complications. Current treatment options in cardiovascular medicine 19, 1-14.

Schnyder, G., Sawhney, N., Whisenant, B., Tsimikas, S., and Turi, Z. G. (2001). Common femoral artery anatomy is influenced by demographics and comorbidity: implications for cardiac and peripheral invasive studies. Catheterization and cardiovascular interventions 53, 289-295.

Shamkhani, W., Rashid, M., and Mamas, M. (2022). Complex, high‐risk percutaneous coronary intervention types, trends, and in‐hospital outcomes among different age groups: An insight from a national registry. Catheterization and Cardiovascular Interventions 100, 711-720.

Sui, Y. G., Teng, S. Y., Qian, J., Wu, Y., Dou, K. F., Tang, Y. D., Qiao, S. B., and Wu, Y. J. (2020). Cross sectional study of retroperitoneal hematoma after invasive intervention in a Chinese population: Prevalence, characteristics, management and outcomes. Experimental and Therapeutic Medicine 20, 2975-2984.

Sunga, K. L., Bellolio, M. F., Gilmore, R. M., and Cabrera, D. (2012). Spontaneous retroperitoneal hematoma: etiology, characteristics, management, and outcome. The Journal of emergency medicine 43, e157-e161.

Thadani, U., and Latif, F. (2013). Retroperitoneal hemorrhage after cardiac catheterization and percutaneous coronary interventions. Cardiology 126, 24-26.

Trimarchi, S., Smith, D. E., Share, D., Jani, S. M., O'Donnell, M., McNamara, R., Riba, A., Kline-Rogers, E., Gurm, H. S., and Moscucci, M. (2010). Retroperitoneal hematoma after percutaneous coronary intervention: prevalence, risk factors, management, outcomes, and predictors of mortality: a report from the BMC2 (Blue Cross Blue Shield of Michigan Cardiovascular Consortium) registry. JACC: cardiovascular interventions 3, 845-850.